ACP | Accelerated Care Plus

The Omnistim^® FX² Pro is the only device of its kind in the industry, featuring ACP's patented Patterned Electrical Neuromuscular Stimulation (PENS) waveform. PENS closely replicates the body's normal muscle and nerve firing patterns (based on EMG research) and has been extensively researched for clinical efficacy. The Omnistim^® FX² Pro offers protocol-use recording capabilities, a built-in lead wire/output tester and evidence-based, "condition-driven" operational protocols for ease-of-use and therapist efficiency. The system also includes a unique hand control feature, which allows the therapist (or patient with therapist oversight) to provide "active-assisted stimulation" for functional exercises such as "sit-to-stand" maneuvers.

The new Omnistim^® FX² Portable enables patients to extend the clinical benefits of electrical stimulation for the management of chronic pain after they have been discharged from their initial therapy program. In some treatment settings, including Outpatient Clinics and Home Health, it may also be recommended as an adjunct therapy used to support an ongoing rehabilitation program. With its "pre-set" operational features, therapists are able to pre-program the unit for simple "at home" patient use. The FX² Portable’s pain management protocols are achieved using Transcutaneous Electrical Stimulation or "TENS", which stimulates nerves to help block pain messages to the brain. Studies have also shown that TENS may help release of the body's own pain-relieving biochemicals.

In addition to its TENS pain management protocols, the Omnistim^® FX² Portable offers ACP’s "Patterned Electrical Neuromuscular Stimulation" or "PENS" – a patented electrical stimulation waveform that closely replicates the body’s normal muscle and nerve firing pattern for effective pain management and muscle re-education. This effect may be used to assist in the treatment of neuromuscular dysfunction, urinary incontinence, stroke, recovery from post-operative joint replacement and other orthopedic diagnoses. This simple-to-use battery operated device provides gentle electrical stimulation through electrode pads that are placed at or near the affected area. Clinicians provide patients with proper direction on electrode placement, treatment protocols, duration of treatment and general operation.

For more information on ACP’s Omnistim^® FX² Portable, please call 800-350-1100.

ACP’s Omnistim^® 500 Pro is a versatile multi-modality electrical stimulation system offering a broad spectrum of therapy options including Full-field Interferential Current (IFC), Transcutaneous Electrical Nerve Stimulation (TENS) and Continuous Medium Frequency Nerve Block for effective management of chronic-intractable pain and/or acute post-traumatic pain. The system’s Medium Frequency Alternating Current (MFAC), Neuromuscular Electrical Stimulation (NMES) and Low Voltage Pulsed Current (LVPC) waveforms support neuromuscular re-education and treatment of muscle disuse atrophy. High Voltage Pulsed Current (HVPC) is used for reduction of chronic-intractable pain and/or acute, post-traumatic pain and to increase circulation for tissue healing applications. The Omnistim^® 500 Pro also features a protocol-use recording function, a built-in lead wire/output tester and evidence-based, "condition-driven" operational protocols for ease-of-use and therapist efficiency.

ACP’s Omnisound^® 3000 Pro line is the most extensively researched ultrasound device available and is supported by numerous research articles for superior outcomes and safety. The 3000 Pro offers evidence-based operational protocols and can be used in "Pulsed" or "Continuous Modes" for both thermal and sub-thermal applications. Importantly, it offers an advanced uniform beam with the lowest Beam Non-uniformity Ratio (BNR) and Peak Area of Maximum Beam Non-uniformity Ratio (PAMBNR) in the industry for consistent heating effects and patient comfort. This exceptional beam uniformity supports safer treatment for geriatric patients with reduced muscle mass and sensitive joints. In addition, the system’s patented Delta T Temperature Dose Control Technology insures reproducible dosage for treatment consistency and clinician efficiency. The system includes two different sized transducer heads (2 & 5 cm) that rotate 360 degrees for more effective and efficient treatment. Each of these transducer heads is designed to be used on targeted surface areas and deep tissue with the flexibility of 1 or 3 MHz power options. The Omnisound 3000 Pro also offers a protocol-use recording function to monitor utilization.

ACP's Megapulse^® II Pulsed Shortwave Diathermy provides state-of-the-art thermal and sub-thermal treatment capabilities to address a wide variety of clinical diagnoses. With its patented Delta T Temperature Dose Control Technology, the system insures reproducible dosage for treatment consistency, ease-of-use and clinician efficiency. In addition, it offers a heavily shielded HI-Q applicator head, which focuses the beam and provides uniformity of heating for patient comfort and safety. The system’s protocols are well researched and output parameters have been carefully selected for use with the elderly. Protocol and device utilization can be monitored using the unit’s integrated protocol-use recording function. ACP’s Megapulse^® II Pulsed Shortwave Diathermy offers demonstrated clinical efficacy and the units are widely recognized as the most reliable and efficient devices in the industry.

ACP’s Neuroprobe^® 500 Pro is the only device of its kind in the industry with the capability to simultaneously deliver electrical stimulation and infrared therapy. The combination of infrared therapy and two channels of electrical stimulation provide clinicians with superior treatment flexibility and efficient concurrent treatment. The unit’s infrared therapy uses high-power Super Luminous Diodes (SLDs) at 630 and 875 nm to safely apply treatment at higher energy levels. The SLDs are embedded in flexible 5" x 7" neoprene pads for convenient placement. The system’s electrical stimulation capabilities include pre-programmed, evidence-based protocols for Trigger Point Stimulation, Transcutaneous Electrical Nerve Stimulation (TENS) and Interferential Current Therapy (IFC).

In addition, it offers innovative treatment protocols for Sequential Motor-Sensory Stimulation and Electrical Nerve Block (Wedensky Inhibition). By delivering several established electrical stimulation protocols simultaneously, sensory and motor pain modulation mechanisms are stimulated to produce multiple neurotransmitters for effective pain management. The combination of these protocols has been extensively published and provides significant improvement over current motor or sensory stimulation when used independently. The Neuroprobe^® 500 Pro also features Nerve Block Protocols that produce a direct anesthetic effect for wound debridement and to reduce pain during contracture management. Nerve block is also used to decrease muscle spasm (tone and spasticity) in patients with neurologic contracture and provides effective treatment for chronic pain management. The Neuroprobe^® 500 Pro features pre-programmed, evidence-based protocols for ease-of-use and fully variable parameters for custom programming. An optional remote treatment probe is also available for Trigger Point Stimulation Techniques or "Hyperstimulation" to produce long-lasting analgesia in the treatment of chronic and acute pain.

ACP’s Omnicycle^™ Elite Motorized Rehabilitation System represents the most advanced therapy cycle technology available today. It accommodates post-acute patients who may not typically be able to participate in therapeutic exercises due to lack of strength, coordination, partial paralysis, respiratory limitations and other conditions. By serving a broader range of neuromuscular and orthopedic diagnoses than traditional "resistance" cycles, the Omnicycle^™ Elite supports expanded therapy services for neurological rehabilitation (Stroke-CVA), orthopedic rehabilitation (TKA, THA, Shoulder, UE) and cardio-pulmonary rehabilitation (COPD).

This advanced motorized rehabilitation system is designed for the complex needs of post-acute and geriatric patients. It accommodates patients who are unable to use traditional exercise equipment, allowing for earlier therapeutic exercise intervention than traditional cycle systems.

The Omnicycle^™ Elite facilitates upper- and lower-extremity exercise in three separate motor-assisted modes: "Assisted" (full motor-assist with a low level of patient participation), "Active-Assist" (partial motor-assist with active patient participation), and "Active" (no motor-assist with full patient participation). The Omnicycle^™ Elite automatically shifts between exercise modes as it detects varying levels of patient participation. The system has been designed with a number of special features to accommodate the complex medical needs of aging adults, including direct wheelchair access, heart rate indicator, spasticity detection and voice command emergency "stop." In addition, the Omnicycle^™ Elite includes a large color touch screen and interactive Biofeedback function to engage and motivate patients mentally and physically, to improve exercise participation and performance. At the end of each training session, the Omnicycle^™ Elite produces a "Training Summary" to track patient progress. This patient summary is printable via an optional wireless Bluetooth^® printer, for patient reporting and objective documentation data.

ACP’s specialty orthotic product line includes a range of splints, braces and appliances for the elbow, wrist, hand, finger, knee and ankle joints. The devices are designed to provide comfortable, "long-term static stretch" to these tightened joints, which helps improve function and range of motion. ACP’s specialized osteoarthritis knee brace relieves pressure on painful arthritic knees and helps correct abnormal gait patterns. Scientific research supports the use of orthotics for a number of prevalent conditions including contractures, stroke recovery, osteoarthritis, neuromuscular disease and accident trauma.

Specialty orthotic devices have been used in several of ACP’s specialized treatment programs for over a decade. When used in conjunction with ACP’s therapeutic modalities, orthotic devices may help improve treatment outcomes and enhance independence.

Scientific literature shows that Progressive Resistance Exercises (PREs) with elastic bands can improve strength among aging adults for improved recovery of function. However, PREs with elastic bands may not be optimized due to inadequate and/or inconsistent resistance levels and stretch characteristics. Without optimal product qualities, strength gains and clinical outcomes may be marginalized.

ACP's Omniband^® products have been developed around the needs of aging adults and offer a number of superior attributes, including consistency of tension and evenly spaced resistance levels, to facilitate proper progressive resistance exercise.

For more information on ACP's New Omniband^® Therapeutic Exercise Bands, please visit our Specialty Rehabiltation page.